Manufactured into plasma-derived therapies

Rare Disease Patients

Single DonorTransfusion

Manufactured into Hyperimmune Ig

(Pooled from many donors,processed & standardized)

SOURCE PLASMACOVID-19 CONVALESCENT PLASMA (CCP)

PLASMA TREATMENTS:IMPORTANT DISTINCTIONS

BLOOD CLOTTING FACTORS: Hemophilia, Von Willebrand disease

ALPHA-1 PROTEINASE INHIBITOR: Alpha-1 antitrypsin deficiency

ALBUMIN: Certain liver conditions, Burns, Shock, Trauma

IMMUNOGLOBULIN (IG): Primary Immunodeficiency diseases, GBS/CIDP, Kawasaki disease, Secondary antibody deficiencies (Cancer), MIS-C, COVID-19

C1 ESTERASE INHIBITOR (C1-INH): Hereditary Angioedema

High RiskIndividuals

COVID-19Patients

AUGU

ST 2

020

#PlasmaDonorsSaveLivesFOR MORE INFORMATION AND WAYS TO DONATE, VISIT:

WWW.DONATINGPLASMA.ORG